Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma
Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer
Micafungin Bests Fluconazole In Phase III Antifungal Trial
Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients
Navelbine+Herceptin: 78% Response In Breast Cancer
Substance From Sea Squirts In Phase II For Breast Cancer
Colorectal Cancer Gene Carriers Seek Screening More Frequently, Study Finds
More Surgical Patients Die When Nurse Caseloads Rise
Neural Stem Cells Track, Treat, Brain Tumors In Mice
Cancer Clinical Trials Approved By NCI Last Month Are Listed
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Peter F. Garrett to people with cancer: Your story has power
- Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy
- Survivorship begins at diagnosis—cancer care system must recognize this
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
